c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Candel Therapeutics stock plummets 35% on prostate cancer BLA delay
Investing.com | Nov 13, 2026 8:47 AM EST
Read original article